nupathe-pharma

Corium

This biopharmaceutical company develops and commercialises central nervous system therapies and drug delivery systems for patients with neurological disorders.

Newronika

This company develops adaptive deep brain stimulation implants that monitor and adjust neural activity for patients with Parkinson's disease and other neurological conditions.

Neumirna Therapeutics

This biotechnology company develops microRNA-based therapies to treat patients with neurological disorders, including drug-resistant epilepsy and Parkinson's disease.

iQure Pharma

This clinical-stage biotech company develops astrocyte-targeted therapeutics to restore glutamate balance for patients with central nervous system disorders such as epilepsy and Parkinson's disease.

Parkinnova Therapeutics

This company develops small molecule phosphodiesterase inhibitors to replenish dopamine and slow disease progression for patients with Parkinson’s disease.

Spherics

This pharmaceutical company develops oral drug delivery technologies to create improved therapeutic products for patients with central nervous system disorders and other medical conditions.

Nuelle

The company develops pharmaceutical treatments for central nervous system conditions, including depression and attention deficit hyperactivity disorder, for patients requiring specialised medical care.

SciNeuro Pharmaceuticals

This company develops neurological medicines and drug delivery platforms for patients with central nervous system diseases, including Alzheimer's and dementia.